Click for best price
Pet Cancer Therapeutics Market Size, Share 2023
Pet cancer therapeutics are the novel drug molecules that exhibit high potential to reduce the effects of cancer, giving access to comprehensive cancer care with minimum side effects. Cancer therapies aims to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatment program such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer.
This report aims to provide a comprehensive presentation of the global market for Pet Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Cancer Therapeutics. This report contains market size and forecasts of Pet Cancer Therapeutics in global, including the following market information:
Global Pet Cancer Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pet Cancer Therapeutics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pet Cancer Therapeutics companies in 2022 (%)
The global Pet Cancer Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The ongoing research activities undertaken by the scientists for the development of novel formulations and therapies is expected to accelerate the market growth.
We surveyed the Pet Cancer Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Cancer Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Global Pet Cancer Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
Global Pet Cancer Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pet Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Cancer Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pet Cancer Therapeutics revenues share in global market, 2022 (%)
Key companies Pet Cancer Therapeutics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pet Cancer Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Cancer Therapeutics, market overview.
Chapter 2: Global Pet Cancer Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Cancer Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Cancer Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Cancer Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pet Cancer Therapeutics Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pet Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pet Cancer Therapeutics Overall Market Size
2.1 Global Pet Cancer Therapeutics Market Size: 2022 VS 2029
2.2 Global Pet Cancer Therapeutics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pet Cancer Therapeutics Sales: 2018-2029
3 Company Landscape
3.1 Top Pet Cancer Therapeutics Players in Global Market
3.2 Top Global Pet Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Pet Cancer Therapeutics Revenue by Companies
3.4 Global Pet Cancer Therapeutics Sales by Companies
3.5 Global Pet Cancer Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pet Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pet Cancer Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Cancer Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Pet Cancer Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Cancer Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pet Cancer Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Combination Therapy
4.1.5 Immunotherapy
4.2 By Type - Global Pet Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Pet Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Pet Cancer Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
4.3 By Type - Global Pet Cancer Therapeutics Sales & Forecasts
4.3.1 By Type - Global Pet Cancer Therapeutics Sales, 2018-2023
4.3.2 By Type - Global Pet Cancer Therapeutics Sales, 2024-2029
4.3.3 By Type - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
4.4 By Type - Global Pet Cancer Therapeutics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pet Cancer Therapeutics Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Mast Cell Cancer
5.1.4 Melanoma
5.1.5 Mammary
5.1.6 Squamous Cell Cancer
5.1.7 Others
5.2 By Application - Global Pet Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Pet Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Pet Cancer Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
5.3 By Application - Global Pet Cancer Therapeutics Sales & Forecasts
5.3.1 By Application - Global Pet Cancer Therapeutics Sales, 2018-2023
5.3.2 By Application - Global Pet Cancer Therapeutics Sales, 2024-2029
5.3.3 By Application - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
5.4 By Application - Global Pet Cancer Therapeutics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pet Cancer Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Pet Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Pet Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Pet Cancer Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
6.3 By Region - Global Pet Cancer Therapeutics Sales & Forecasts
6.3.1 By Region - Global Pet Cancer Therapeutics Sales, 2018-2023
6.3.2 By Region - Global Pet Cancer Therapeutics Sales, 2024-2029
6.3.3 By Region - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pet Cancer Therapeutics Revenue, 2018-2029
6.4.2 By Country - North America Pet Cancer Therapeutics Sales, 2018-2029
6.4.3 US Pet Cancer Therapeutics Market Size, 2018-2029
6.4.4 Canada Pet Cancer Therapeutics Market Size, 2018-2029
6.4.5 Mexico Pet Cancer Therapeutics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pet Cancer Therapeutics Revenue, 2018-2029
6.5.2 By Country - Europe Pet Cancer Therapeutics Sales, 2018-2029
6.5.3 Germany Pet Cancer Therapeutics Market Size, 2018-2029
6.5.4 France Pet Cancer Therapeutics Market Size, 2018-2029
6.5.5 U.K. Pet Cancer Therapeutics Market Size, 2018-2029
6.5.6 Italy Pet Cancer Therapeutics Market Size, 2018-2029
6.5.7 Russia Pet Cancer Therapeutics Market Size, 2018-2029
6.5.8 Nordic Countries Pet Cancer Therapeutics Market Size, 2018-2029
6.5.9 Benelux Pet Cancer Therapeutics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pet Cancer Therapeutics Revenue, 2018-2029
6.6.2 By Region - Asia Pet Cancer Therapeutics Sales, 2018-2029
6.6.3 China Pet Cancer Therapeutics Market Size, 2018-2029
6.6.4 Japan Pet Cancer Therapeutics Market Size, 2018-2029
6.6.5 South Korea Pet Cancer Therapeutics Market Size, 2018-2029
6.6.6 Southeast Asia Pet Cancer Therapeutics Market Size, 2018-2029
6.6.7 India Pet Cancer Therapeutics Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pet Cancer Therapeutics Revenue, 2018-2029
6.7.2 By Country - South America Pet Cancer Therapeutics Sales, 2018-2029
6.7.3 Brazil Pet Cancer Therapeutics Market Size, 2018-2029
6.7.4 Argentina Pet Cancer Therapeutics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Cancer Therapeutics Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pet Cancer Therapeutics Sales, 2018-2029
6.8.3 Turkey Pet Cancer Therapeutics Market Size, 2018-2029
6.8.4 Israel Pet Cancer Therapeutics Market Size, 2018-2029
6.8.5 Saudi Arabia Pet Cancer Therapeutics Market Size, 2018-2029
6.8.6 UAE Pet Cancer Therapeutics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aratana Therapeutics, Inc
7.1.1 Aratana Therapeutics, Inc Company Summary
7.1.2 Aratana Therapeutics, Inc Business Overview
7.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Major Product Offerings
7.1.4 Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 Aratana Therapeutics, Inc Key News & Latest Developments
7.2 AB Science
7.2.1 AB Science Company Summary
7.2.2 AB Science Business Overview
7.2.3 AB Science Pet Cancer Therapeutics Major Product Offerings
7.2.4 AB Science Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 AB Science Key News & Latest Developments
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Company Summary
7.3.2 Boehringer Ingelheim International GmbH Business Overview
7.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.4 Zenoaq
7.4.1 Zenoaq Company Summary
7.4.2 Zenoaq Business Overview
7.4.3 Zenoaq Pet Cancer Therapeutics Major Product Offerings
7.4.4 Zenoaq Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 Zenoaq Key News & Latest Developments
7.5 Morphogenesis, Inc
7.5.1 Morphogenesis, Inc Company Summary
7.5.2 Morphogenesis, Inc Business Overview
7.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Major Product Offerings
7.5.4 Morphogenesis, Inc Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Morphogenesis, Inc Key News & Latest Developments
7.6 VetDC, Inc
7.6.1 VetDC, Inc Company Summary
7.6.2 VetDC, Inc Business Overview
7.6.3 VetDC, Inc Pet Cancer Therapeutics Major Product Offerings
7.6.4 VetDC, Inc Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 VetDC, Inc Key News & Latest Developments
7.7 Karyopharm Therapeutics, Inc
7.7.1 Karyopharm Therapeutics, Inc Company Summary
7.7.2 Karyopharm Therapeutics, Inc Business Overview
7.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Major Product Offerings
7.7.4 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Karyopharm Therapeutics, Inc Key News & Latest Developments
7.8 Rhizen Pharmaceutical SA
7.8.1 Rhizen Pharmaceutical SA Company Summary
7.8.2 Rhizen Pharmaceutical SA Business Overview
7.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Major Product Offerings
7.8.4 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Rhizen Pharmaceutical SA Key News & Latest Developments
7.9 Regeneus Ltd.
7.9.1 Regeneus Ltd. Company Summary
7.9.2 Regeneus Ltd. Business Overview
7.9.3 Regeneus Ltd. Pet Cancer Therapeutics Major Product Offerings
7.9.4 Regeneus Ltd. Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Regeneus Ltd. Key News & Latest Developments
7.10 Oasmia Pharmaceuticals AB
7.10.1 Oasmia Pharmaceuticals AB Company Summary
7.10.2 Oasmia Pharmaceuticals AB Business Overview
7.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Major Product Offerings
7.10.4 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Oasmia Pharmaceuticals AB Key News & Latest Developments
7.11 Zoetis
7.11.1 Zoetis Company Summary
7.11.2 Zoetis Pet Cancer Therapeutics Business Overview
7.11.3 Zoetis Pet Cancer Therapeutics Major Product Offerings
7.11.4 Zoetis Pet Cancer Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 Zoetis Key News & Latest Developments
8 Global Pet Cancer Therapeutics Production Capacity, Analysis
8.1 Global Pet Cancer Therapeutics Production Capacity, 2018-2029
8.2 Pet Cancer Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Cancer Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pet Cancer Therapeutics Supply Chain Analysis
10.1 Pet Cancer Therapeutics Industry Value Chain
10.2 Pet Cancer Therapeutics Upstream Market
10.3 Pet Cancer Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Cancer Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pet Cancer Therapeutics in Global Market
Table 2. Top Pet Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pet Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pet Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Pet Cancer Therapeutics Sales by Companies, (K Units), 2018-2023
Table 6. Global Pet Cancer Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pet Cancer Therapeutics Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Pet Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Pet Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pet Cancer Therapeutics Sales (K Units), 2018-2023
Table 15. By Type - Global Pet Cancer Therapeutics Sales (K Units), 2024-2029
Table 16. By Application ? Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pet Cancer Therapeutics Sales (K Units), 2018-2023
Table 20. By Application - Global Pet Cancer Therapeutics Sales (K Units), 2024-2029
Table 21. By Region ? Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pet Cancer Therapeutics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pet Cancer Therapeutics Sales (K Units), 2018-2023
Table 25. By Region - Global Pet Cancer Therapeutics Sales (K Units), 2024-2029
Table 26. By Country - North America Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pet Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pet Cancer Therapeutics Sales, (K Units), 2018-2023
Table 29. By Country - North America Pet Cancer Therapeutics Sales, (K Units), 2024-2029
Table 30. By Country - Europe Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pet Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pet Cancer Therapeutics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pet Cancer Therapeutics Sales, (K Units), 2024-2029
Table 34. By Region - Asia Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pet Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pet Cancer Therapeutics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pet Cancer Therapeutics Sales, (K Units), 2024-2029
Table 38. By Country - South America Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pet Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pet Cancer Therapeutics Sales, (K Units), 2018-2023
Table 41. By Country - South America Pet Cancer Therapeutics Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pet Cancer Therapeutics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pet Cancer Therapeutics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pet Cancer Therapeutics Sales, (K Units), 2024-2029
Table 46. Aratana Therapeutics, Inc Company Summary
Table 47. Aratana Therapeutics, Inc Pet Cancer Therapeutics Product Offerings
Table 48. Aratana Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Aratana Therapeutics, Inc Key News & Latest Developments
Table 50. AB Science Company Summary
Table 51. AB Science Pet Cancer Therapeutics Product Offerings
Table 52. AB Science Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. AB Science Key News & Latest Developments
Table 54. Boehringer Ingelheim International GmbH Company Summary
Table 55. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Product Offerings
Table 56. Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Boehringer Ingelheim International GmbH Key News & Latest Developments
Table 58. Zenoaq Company Summary
Table 59. Zenoaq Pet Cancer Therapeutics Product Offerings
Table 60. Zenoaq Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Zenoaq Key News & Latest Developments
Table 62. Morphogenesis, Inc Company Summary
Table 63. Morphogenesis, Inc Pet Cancer Therapeutics Product Offerings
Table 64. Morphogenesis, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Morphogenesis, Inc Key News & Latest Developments
Table 66. VetDC, Inc Company Summary
Table 67. VetDC, Inc Pet Cancer Therapeutics Product Offerings
Table 68. VetDC, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. VetDC, Inc Key News & Latest Developments
Table 70. Karyopharm Therapeutics, Inc Company Summary
Table 71. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Product Offerings
Table 72. Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Karyopharm Therapeutics, Inc Key News & Latest Developments
Table 74. Rhizen Pharmaceutical SA Company Summary
Table 75. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Product Offerings
Table 76. Rhizen Pharmaceutical SA Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Rhizen Pharmaceutical SA Key News & Latest Developments
Table 78. Regeneus Ltd. Company Summary
Table 79. Regeneus Ltd. Pet Cancer Therapeutics Product Offerings
Table 80. Regeneus Ltd. Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Regeneus Ltd. Key News & Latest Developments
Table 82. Oasmia Pharmaceuticals AB Company Summary
Table 83. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Product Offerings
Table 84. Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Oasmia Pharmaceuticals AB Key News & Latest Developments
Table 86. Zoetis Company Summary
Table 87. Zoetis Pet Cancer Therapeutics Product Offerings
Table 88. Zoetis Pet Cancer Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Zoetis Key News & Latest Developments
Table 90. Pet Cancer Therapeutics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Pet Cancer Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Pet Cancer Therapeutics Production by Region, 2018-2023 (K Units)
Table 93. Global Pet Cancer Therapeutics Production by Region, 2024-2029 (K Units)
Table 94. Pet Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 95. Pet Cancer Therapeutics Market Drivers in Global Market
Table 96. Pet Cancer Therapeutics Market Restraints in Global Market
Table 97. Pet Cancer Therapeutics Raw Materials
Table 98. Pet Cancer Therapeutics Raw Materials Suppliers in Global Market
Table 99. Typical Pet Cancer Therapeutics Downstream
Table 100. Pet Cancer Therapeutics Downstream Clients in Global Market
Table 101. Pet Cancer Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pet Cancer Therapeutics Segment by Type in 2022
Figure 2. Pet Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Pet Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pet Cancer Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pet Cancer Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. Pet Cancer Therapeutics Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Cancer Therapeutics Revenue in 2022
Figure 9. By Type - Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 12. By Type - Global Pet Cancer Therapeutics Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 16. By Application - Global Pet Cancer Therapeutics Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Pet Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pet Cancer Therapeutics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 21. By Country - North America Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 23. US Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 28. Germany Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. France Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 37. China Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. India Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 44. Brazil Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pet Cancer Therapeutics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pet Cancer Therapeutics Sales Market Share, 2018-2029
Figure 48. Turkey Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pet Cancer Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pet Cancer Therapeutics Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Pet Cancer Therapeutics by Region, 2022 VS 2029
Figure 54. Pet Cancer Therapeutics Industry Value Chain
Figure 55. Marketing Channels
